6846 logo

Greenyn Biotechnology TPEX:6846 Stock Report

Last Price

NT$78.50

Market Cap

NT$2.1b

7D

-0.1%

1Y

-25.9%

Updated

24 Apr, 2024

Data

Company Financials

Greenyn Biotechnology Co., Ltd

TPEX:6846 Stock Report

Market Cap: NT$2.1b

6846 Stock Overview

Greenyn Biotechnology Co., Ltd, a dietary supplement company, develops, manufactures, and sells health products in Taiwan and internationally.

6846 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health0/6
Dividends0/6

Greenyn Biotechnology Co., Ltd Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Greenyn Biotechnology
Historical stock prices
Current Share PriceNT$78.50
52 Week HighNT$114.00
52 Week LowNT$71.00
Beta0
1 Month Change-2.73%
3 Month Change2.88%
1 Year Change-25.94%
3 Year Changen/a
5 Year Changen/a
Change since IPO-5.42%

Recent News & Updates

Recent updates

Shareholder Returns

6846TW Personal ProductsTW Market
7D-0.1%0.8%-1.6%
1Y-25.9%-13.5%25.9%

Return vs Industry: 6846 underperformed the TW Personal Products industry which returned -13.5% over the past year.

Return vs Market: 6846 underperformed the TW Market which returned 25.9% over the past year.

Price Volatility

Is 6846's price volatile compared to industry and market?
6846 volatility
6846 Average Weekly Movement2.5%
Personal Products Industry Average Movement3.9%
Market Average Movement4.6%
10% most volatile stocks in TW Market8.6%
10% least volatile stocks in TW Market2.2%

Stable Share Price: 6846 has not had significant price volatility in the past 3 months.

Volatility Over Time: 6846's weekly volatility (2%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2012n/an/awww.greenynbio.com

Greenyn Biotechnology Co., Ltd, a dietary supplement company, develops, manufactures, and sells health products in Taiwan and internationally. The company offers proprietary ingredients, such as Insumate, a bitter melon extract; Antromax, an antrodia cinnamomea; and Zymologist 101 Phyto fermented drink. It also provides functional formulas for youth and beauty series, digestive health series, brain health series, body regulation series, throat moistening series, hair care series, clear eye series, colorful lifestyle series, joint health series, nutritional supplement series, energy supplement series, immune modulation series, low burden series, sleep aid series, body curve series, circulation series, man power series, women’s intimate health series, and mature woman series.

Greenyn Biotechnology Co., Ltd Fundamentals Summary

How do Greenyn Biotechnology's earnings and revenue compare to its market cap?
6846 fundamental statistics
Market capNT$2.10b
Earnings (TTM)NT$0
Revenue (TTM)n/a

n/a

P/E Ratio

n/a

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
6846 income statement (TTM)
RevenueNT$0
Cost of RevenueNT$0
Gross ProfitNT$0
Other ExpensesNT$0
EarningsNT$0

Last Reported Earnings

n/a

Next Earnings Date

n/a

Earnings per share (EPS)0
Gross Margin0.00%
Net Profit Margin0.00%
Debt/Equity Ratio0.0%

How did 6846 perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.